- VTR +0.21%
Search results
- 48.47Add to watchlist+0.10 (+0.21%)At close: Wed. May 22, 2024 4:00 PM EDT · Delayed Quote (USD) · Pre-Market Time
- Open48.24High48.67Low48.21
- Mkt Cap19.62BP/E (TTM)N/ADiv & Yield1.80 & 3.71%
- Prev. Close48.3752 Wk. Low39.3352 Wk. High50.99
What analysts are sayingTop storiesInsider Sale: Director Walter Rakowich Sells Shares of Ventas Inc (VTR)Yahoo Finance · 6 days ago- VTR +0.21%
Insider Sale at Ventas Inc (VTR): SVP, Chief Accounting Officer Gregory Liebbe Sells SharesYahoo Finance · 1 week ago- VTR +0.21%
Ventas (VTR) Reports Q1 Earnings: What Key Metrics Have to SayYahoo Finance · 3 weeks agoRelated stocks
Find the latest Ventas, Inc. (VTR) stock quote, history, news and other vital information to help you with your stock trading and investing.
2 days ago · Get the latest VTR stock price, performance, earnings, dividend, and analyst ratings. Ventas Inc. is a healthcare real estate investment trust that owns and operates senior housing and healthcare properties.
People also ask
Should you buy Ventas (VTR) stock?
What are VTR share price targets?
Where can I buy VTR stock?
Should you buy viatris (VTRs) stock?
Apr 8, 2024 · Get the latest stock price, key data, dividend, and earnings information for Ventas, Inc. (VTR), a real estate investment trust. See how VTR performs in the market and compare it with other ETFs and REITs.
Get the latest Ventas Inc (VTR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
View the latest Ventas Inc. (VTR) stock price, news, historical charts, analyst ratings and financial information from WSJ.
- 486
May 15, 2024 · Ventas is a healthcare REIT that owns and operates senior housing, medical office, hospital, life science, and skilled nursing properties. The stock is trading at a 38% discount to fair value and has a 4.09% dividend yield as of Apr 23, 2024.
View the latest Ventas Inc. (VTR) stock price, news, historical charts, analyst ratings and financial information from WSJ.